The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
MicroRNAs in NF- B signaling
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The miR-155 is a multifunctional microRNA and it can modulate inflammatory responses in both a positive and negative way [40-48].”
From miR-155 induction in microglial cells suppresses Japanese encephalitis virus replication and negatively modulates innate immune responses (2014) · cites this paper as [48]
In the citing paper
“Besides its positive role in NF-κB activation and subsequent pro-inflammatory response, accumulating evidence has demonstrated that it can constitute a negative feedback loop in the NF-κB signaling pathway by targeting multiple key proteins, which ultimately leads to repression of, or at least the limitation of NF-κB activation in response to viral or microbial stimuli [41,42,45-48].”
From miR-155 induction in microglial cells suppresses Japanese encephalitis virus replication and negatively modulates innate immune responses (2014) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
The impact of microRNAs on protein output
Baek, D., Villén, J., Shin, C., Camargo, F. D., Gygi, S. P., & Bartel, D. P. (2008) · Nature · doi:10.1038/nature07242 · Cited by 3,592
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma
Medina, P. P., Nolde, M., & Slack, F. J. (2010) · Nature · doi:10.1038/nature09284 · Cited by 971
Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
Hatley, M. E., Patrick, D. M., Garcia, M. R., Richardson, J. A., Bassel-Duby, R., van Rooij, E., & Olson, E. N. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.013 · Cited by 626 · cited 2×
“Work from animal models provides no insight in this regard: the expression of miR-21 target genes is not widely upregulated in tissues of miR-21 knockout mice as one would expect (Hatley et al., 2010; Patrick et al., 2010).”
Bazzoni, F., Rossato, M., Fabbri, M., Gaudiosi, D., Mirolo, M., Mori, L., Tamassia, N., Mantovani, A., Cassatella, M. A., & Locati, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810909106 · Cited by 548 · cited 3×
“miR-9 is another miRNA induced by LPS via MyD88 and NF-kB (Bazzoni et al., 2009).”
InfluentialLukiw, W. J., Zhao, Y., & Cui, J. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805371200 · Cited by 441
Flagged first, then by citations
Research works printed but not linked: 86
- Annunziata, 2007, Cancer cell, 12, 115, 10.1016/j.ccr.2007.07.004 · DOI · Paper page
- Aqeilan, 2010, Cell death and differentiation, 17, 215, 10.1038/cdd.2009.69 · DOI
- 2011, Journal of Biological Chemistry, 286, 1436, 10.1074/jbc.M110.145870 · DOI · Paper page
- Baud, 2009, Nature reviews. Drug discovery, 8, 33, 10.1038/nrd2781 · DOI
- BHARTI, 2002, Annals of the New York Academy of Sciences, 973, 392, 10.1111/j.1749-6632.2002.tb04671.x · DOI
- Bhaumik, 2008, Oncogene, 27, 5643, 10.1038/onc.2008.171 · DOI
- Bonci, 2008, Nature medicine, 14, 1271, 10.1038/nm.1880 · DOI
- Borralho, 2009, FEBS Journal, 276, 6689, 10.1111/j.1742-4658.2009.07383.x · DOI
- 2009, Human Molecular Genetics, 18, 4818, 10.1093/hmg/ddp446 · DOI
- Chen, 2008, Oncogene, 27, 4712, 10.1038/onc.2008.112 · DOI
- Conti, 2009, Journal of neuro-oncology, 93, 325, 10.1007/s11060-009-9797-4 · DOI
- 2006, PNAS, 103, 7024, 10.1073/pnas.0602266103 · DOI
- 2005, PNAS, 102, 3627, 10.1073/pnas.0500613102 · DOI
- Elmen, 2008, Nature; Physical Science (London), 452, 896, 10.1038/nature06783 · DOI · Paper page
- 2002, PNAS, 99, 14212, 10.1073/pnas.212306199 · DOI
- Froese, 2006, Molecular and Cellular Biology, 26, 293, 10.1128/MCB.26.1.293-302.2006 · DOI
- 2007, Blood, 109, 4944, 10.1182/blood-2006-12-062398 · DOI
- 2007, PNAS, 104, 16170, 10.1073/pnas.0703942104 · DOI
- Greither, 2010, International journal of cancer. Journal international du cancer, 126, 73, 10.1002/ijc.24687 · DOI
- Guo, 2009, FEBS Journal, 276, 5537, 10.1111/j.1742-4658.2009.07237.x · DOI
- Guo, 2010, Nature; Physical Science (London), 466, 835, 10.1038/nature09267 · DOI · Paper page
- Hafner, 2010, Cell, 141, 129, 10.1016/j.cell.2010.03.009 · DOI · Paper page
- 2010, Journal of Biological Chemistry, 285, 9383, 10.1074/jbc.M109.095612 · DOI
- 2009, Cancer Research, 69, 1279, 10.1158/0008-5472.CAN-08-3559 · DOI
- Iliopoulos, 2009, Cell, 139, 693, 10.1016/j.cell.2009.10.014 · DOI · Paper page
- Iliopoulos, 2010, Molecular cell, 39, 493, 10.1016/j.molcel.2010.07.023 · DOI · Paper page
- Imaizumi, 2010, American journal of nephrology, 32, 462, 10.1159/000321365 · DOI
- Inoue, 2007, Cancer Science, 98, 268, 10.1111/j.1349-7006.2007.00389.x · DOI
- Iorio, 2005, Cancer Research, 65, 7065, 10.1158/0008-5472.CAN-05-1783 · DOI · Paper page
- Jiang, 2008, Clinical Cancer Research, 14, 419, 10.1158/1078-0432.CCR-07-0523 · DOI
- 2008, Science, 321, 1801, 10.1126/science.1164368 · DOI · Paper page
- 2008, Blood, 111, 5078, 10.1182/blood-2008-01-133355 · DOI
- Karin, 2005, Nature reviews. Immunology, 5, 749, 10.1038/nri1703 · DOI
- Karin, 2002, Nature reviews. Cancer, 2, 301, 10.1038/nrc780 · DOI
- Keats, 2007, Cancer cell, 12, 131, 10.1016/j.ccr.2007.07.003 · DOI · Paper page
- Kluiver, 2005, The Journal of pathology, 207, 243, 10.1002/path.1825 · DOI
- Kluiver, 2007, Oncogene, 26, 3769, 10.1038/sj.onc.1210147 · DOI
- 2008, PNAS, 105, 20798, 10.1073/pnas.0806491106 · DOI
- Lawrie, 2007, International journal of cancer. Journal international du cancer, 121, 1156, 10.1002/ijc.22800 · DOI
- Lee, 2007, International journal of cancer. Journal international du cancer, 120, 1046, 10.1002/ijc.22394 · DOI
- 2008, Science, 319, 1676, 10.1126/science.1153629 · DOI
- Li, 2010, Nature immunology, 11, 799, 10.1038/ni.1918 · DOI
- 2010, Cancer Research, 70, 1486, 10.1158/0008-5472.CAN-09-2792 · DOI
- Lindenblatt, 2009, Cell cycle (Georgetown, Tex.), 8, 2019, 10.4161/cc.8.13.8816 · DOI
- Liu, 2010, Cancer cell, 17, 333, 10.1016/j.ccr.2010.03.008 · DOI
- 2008, Diabetes, 57, 2728, 10.2337/db07-1252 · DOI
- Lu, 2008, Oncogene, 27, 4373, 10.1038/onc.2008.72 · DOI · Paper page
- Lu, 2011, The EMBO Journal, 30, 57, 10.1038/emboj.2010.296 · DOI
- 2010, American Journal of Physiology - Gastrointestinal and Liver Physiology, 298, G535, 10.1152/ajpgi.00338.2009 · DOI
- Mott, 2010, Journal of cellular biochemistry, 110, 1155, 10.1002/jcb.22630 · DOI · Paper page
- 2008, Blood, 111, 2825, 10.1182/blood-2007-06-096784 · DOI
- 2008, Journal of Clinical Endocrinology & Metabolism, 93, 1600, 10.1210/jc.2007-2696 · DOI
- Nourbakhsh, 1999, The EMBO Journal, 18, 6415, 10.1093/emboj/18.22.6415 · DOI
- 2001, Journal of Biological Chemistry, 276, 4501, 10.1074/jbc.M007532200 · DOI
- 2007, PNAS, 104, 1604, 10.1073/pnas.0610731104 · DOI · Paper page
- 2010, Journal of Clinical Endocrinology & Metabolism, 95, 1421, 10.1210/jc.2009-1128 · DOI
- Patrick, 2010, Journal of Clinical Investigation, 120, 3912, 10.1172/JCI43604 · DOI
- Pecot, 2011, Nature reviews. Cancer, 11, 59, 10.1038/nrc2966 · DOI
- Perry, 2008, The Journal of Immunology, 180, 5689, 10.4049/jimmunol.180.8.5689 · DOI · Paper page
- Rai, 2008, Cancer genetics and cytogenetics, 181, 8, 10.1016/j.cancergencyto.2007.10.008 · DOI
- 2010, Diabetes, 59, 978, 10.2337/db09-0881 · DOI
- Ryseck, 1995, Molecular and Cellular Biology, 15, 3100, 10.1128/MCB.15.6.3100 · DOI
- Sarkar, 2007, Toxicology and applied pharmacology, 224, 326, 10.1016/j.taap.2006.11.007 · DOI
- Schetter, 2008, JAMA, 299, 425, 10.1001/jama.299.4.425 · DOI
- Sheedy, 2010, Nature immunology, 11, 141, 10.1038/ni.1828 · DOI · Paper page
- Shi, 2008, Brain research, 1236, 185, 10.1016/j.brainres.2008.07.085 · DOI
- 2011, Carcinogenesis, 32, 240, 10.1093/carcin/bgq240 · DOI
- 2010, Cancer Research, 70, 5096, 10.1158/0008-5472.CAN-09-4148 · DOI
- 2010, American Journal of Physiology - Heart and Circulatory Physiology, 299, H1077, 10.1152/ajpheart.00212.2010 · DOI
- 2011, Journal of Biological Chemistry, 286, 1675, 10.1074/jbc.M110.177063 · DOI
- Tili, 2007, The Journal of Immunology, 179, 5082, 10.4049/jimmunol.179.8.5082 · DOI · Paper page
- Trompouki, 2003, Nature; Physical Science (London), 424, 793, 10.1038/nature01803 · DOI
- van den Berg, 2003, Genes, chromosomes & cancer, 37, 20, 10.1002/gcc.10186 · DOI
- 2007, 27, 847
- Wan, 2010, Molecular cancer [electronic resource], 9, 16, 10.1186/1476-4598-9-16 · DOI
- Wang, 2008, Cancer cell, 14, 369, 10.1016/j.ccr.2008.10.006 · DOI
- Wang, 2009, Hepatology (Baltimore, Md.), 50, 1152, 10.1002/hep.23100 · DOI
- Wang, 2010, Oncogene, 29, 128, 10.1038/onc.2009.302 · DOI · Paper page
- Williams, 2008, Biochemical Society Transactions, 36, 1211, 10.1042/BST0361211 · DOI
- 2009, Journal of Infectious Diseases, 200, 916, 10.1086/605443 · DOI · Paper page
- Yanaihara, 2006, Cancer cell, 9, 189, 10.1016/j.ccr.2006.01.025 · DOI · Paper page
- Yin, 2010, Oncogene, 29, 3545, 10.1038/onc.2010.111 · DOI
- Young, 2010, Molecular Interventions, 10, 76, 10.1124/mi.10.2.5 · DOI
- Zhang, 2009, Hepatology (Baltimore, Md.), 50, 490, 10.1002/hep.23008 · DOI
- 2009, 5, 100
- 2010, Nucleic Acids Research, 38, 3222, 10.1093/nar/gkq056 · DOI
Cited by
Sorted by citations
NF-κB, inflammation, immunity and cancer: coming of age
Taniguchi, K., & Karin, M. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.142 · Cited by 2,679
Resolution of Inflammation: What Controls Its Onset?
Sugimoto, M. A., Sousa, L. P., Pinho, V., Perretti, M., & Teixeira, M. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00160 · Cited by 638
MicroRNAs: New Regulators of Toll-Like Receptor Signalling Pathways
He, X., Jing, Z., & Cheng, G. (2014) · BioMed Research International · doi:10.1155/2014/945169 · Cited by 238
Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway
Sheth, S., Jajoo, S., Kaur, T., Mukherjea, D., Sheehan, K., Rybak, L. P., & Ramkumar, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051655 · Cited by 225
DNA damage response (DDR) and senescence: shuttled inflamma-miRNAs on the stage of inflamm-aging
Olivieri, F., Albertini, M. C., Orciani, M., Ceka, A., Cricca, M., Procopio, A. D., & Bonafè, M. (2015) · Oncotarget · doi:10.18632/oncotarget.5899 · Cited by 163
Metadata
- Authors
- Ma, X., Becker Buscaglia, L. E., Barker, J. R., & Li, Y.
- Venue
- Journal of Molecular Cell Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-04-18
- Volume
- 3
- Issue
- 3
- Pages
- 159-166
- ISSN
- 1674-2788
- Cited by
- 542
- References
- 9
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review